Overview
Ruth Arnon is a immunology specialist with an H-index of 66 at Weizmann Institute (Member). Has been published in New England Journal of Medicine, Proceedings of the National Academy of Sciences, Journal of Neuroscience. Based in Unknown, Unknown, Global.
Biography
Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Publication Timeline
Published In
Eur J ImmunolPharmacol RevIsr Med Assoc JInt J Mol SciExpert Rev Vaccines
Key Publications
Prof. Michael Sela (1924-2022).
Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair.
Glatiramer Acetate: from Bench to Bed and Back.
Astrocytes in Multiple Sclerosis-Essential Constituents with Diverse Multifaceted Functions.
Epitope-based vaccine against influenza.
Areas of Expertise
Medical Specialties
Clinical Knowledge & Procedures
Media Archive